The U.S. Federal Trade Commission (FTC) recently announced a settlement resolving its competitive concerns over the merger of two leading generic drug manufacturers – Teva and Allergan. In July 2015, Teva agreed to acquire...more
8/1/2016
/ Abbreviated New Drug Application (ANDA) ,
Actavis Inc. ,
Divestiture ,
Enforcement Actions ,
Federal Trade Commission (FTC) ,
Generic Drugs ,
Manufacturers ,
Mergers ,
Pharmaceutical Industry ,
Settlement ,
Teva Pharmaceuticals